Inactive Instrument

Orphée SA

Equities

ORP

CH0197761098

Advanced Medical Equipment & Technology

Tomasz Tuora acquired an additional 9.02% stake in Orphee SA for PLN 11.3 million.

July 24, 2014

Tomasz Tuora acquired an additional 9.02% stake in Orphee SA (WSE:ORP) for PLN 11.3 million on July 25, 2014. Tomasz Tuora acquired an additional 3 million shares of Orphee for PLN 3.75 per share and pursuant to the transaction, Tomasz Tuora owns 3.5 million shares of Orphee.

Tomasz Tuora completed the acquisition of an additional 9.02% stake in Orphee SA (WSE:ORP) on July 25, 2014.

Latest news about Orphée SA

PZ Cormay S.A. acquired unknown minority stake in Orphée SA for CHF 1.2 million.	20-11-16	CI
PZ Cormay S.A. completed the acquisition of 0.54% stake in Orphée SA for PLN 0.37 million.	20-02-05	CI
PZ Cormay S.A. made a tender offer to acquire remaining 2.9% stake in Orphée SA for PLN 2 million.	19-12-10	CI
PZ Cormay S.A. agreed to acquire remaining 11.6% stake in Orphée SA for PLN 7.8 million.	19-09-04	CI
MED II, managed by ArchiMed SAS completed the acquisition of DIESSE Diagnostica Senese S.p.A. from Orphée SA and founders for €14.5 million.	19-05-12	CI
Orphée Is In Talks To Sell Stake In DIESSE	19-02-27	CI
MED II, managed by ArchiMed SAS signed a letter of intent to acquire DIESSE Diagnostica Senese S.p.A. from Orphée SA and founders.	18-09-27	CI
PZ Cormay S.A. cancelled the acquisition of an additional 12.95% stake in Orphée SA from TTL 1 SP Z O O.	17-05-17	CI
PZ Cormay S.A. signed an agreement to acquire additional 12.95% stake in Orphée SA from TTL 1 SP Z O O for PLN 10 million.	16-05-17	CI
Orphée SA completed the acquisition of TT Management sp. z o.o. from Planezza SA.	15-09-02	CI
Tadeusz Tuora sold 6.6% stake in Orphée SA for PLN 2.1 million.	15-07-10	CI
Tranche Update on Orphée SA's Equity Buyback Plan announced on February 23, 2015.	15-04-03	CI
Orphée SA's Equity Buyback announced on February 26, 2015, has expired with repurchase of 3,859,118 shares, for PLN 34.3 million.	15-04-02	CI
TTL 1 SP Z O O and another shareholder completed the acquisition of 27% stake in Orphée SA from PZ Cormay S.A..	15-03-03	CI
TTL 1 SP Z O O and another shareholder agreed to acquire 27% stake in Orphée SA from PZ Cormay S.A. for PLN 20.8 million.	15-02-25	CI
Orphée SA announces an Equity Buyback for 3,860,850 shares, representing 10% for PLN 34.36 million.	15-02-23	CI
Orphée SA authorizes a Buyback plan.	15-02-22	CI
IPOPEMA TFI S.A. acquired an additional 4.58% stake in Orphee SA.	14-12-28	CI
Orphée SA entered into an agreement to acquire TT Management sp. z o.o. from Planezza SA for CHF 2.4 million.	14-09-02	CI
Tomasz Tuora acquired an additional 9.02% stake in Orphee SA for PLN 11.3 million.	14-07-24	CI
Orphée SA completed the acquisition of 50% stake in DIESSE Diagnostica Senese S.p.A.	13-02-27	CI
Orphée SA agreed to acquire 50% stake in DIESSE Diagnostica Senese S.p.A. for €15 million.	13-02-11	CI

Chart Orphée SA

Duration

Period

More charts

Company Profile

Orphee SA is a Switzerland-based company engaged in development and marketing of instrumentation for the haematology diagnostics. The Company operates in over 100 countries worldwide, including Brazil, Bangladesh, China, Philippines, Mexico, Romania, Poland, among others, and is primarily engaged in in-vitro diagnostics (IVD) market. It divides its business into three segments: Sale and Production of Haematology and Electrolyte Analyzers, offering six types of analyzers under the name Mythic (Mythic 18, Mythic 18 Vet, Mythic 22 OT, Mythic 22 CT, Mythic 22 AL, Mythic Lyte); Sale and Production of Blood Test Reagents, and Sale of Spare Parts for Offered Analyzers. The Company is a subsidiary of PZ Cormay SA. On September 1, 2014, the Company acquired 100% stake in TT Management Sp z o o to enable execution of the restructuring plan of Cormay group which aims at transferring production and distribution activity of Cormay group to Orphee.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
SARTORIUS AG	-27.52%	16.28B
QUIDELORTHO CORPORATION	-40.04%	2.96B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+15.16%	1.79B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-6.86%	1.52B
BIOTAGE AB	+38.67%	1.33B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-15.36%	968M
REVENIO GROUP OYJ	+3.53%	840M
CONTEC MEDICAL SYSTEMS CO.,LTD	-26.08%	833M
CELLAVISION AB	+23.58%	630M

Medical Diagnostic & Testing Equipment